scispace - formally typeset
A

Anastasios Tsarouchas

Researcher at Aristotle University of Thessaloniki

Publications -  24
Citations -  187

Anastasios Tsarouchas is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 16 publications receiving 100 citations.

Papers
More filters
Journal ArticleDOI

Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers

TL;DR: Great effort is made to reduce the time to diagnosis, as treatment in the initial stages of the disease is tied to better prognosis, and the results are highly sensitive and specific diagnostic modalities that are also reasonably cost effective.
Journal ArticleDOI

A Patient-Oriented App (ThessHF) to Improve Self-Care Quality in Heart Failure: From Evidence-Based Design to Pilot Study.

TL;DR: The Hellenic Educational Self-care and Support Heart Failure app (ThessHF app) as mentioned in this paper was developed to promote remote self-care support in patients with heart failure, which was tested by patients with HF, who rated its design and content by means of the Post-Study System Usability Questionnaire (PSSUQ).
Journal ArticleDOI

Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.

TL;DR: According to this research, colchicine may be an agent of interest in the treatment of COVID-19 via its anti-inflammatory properties, however, there are potential drug interactions with cytochrome P450 3A4 inhibitors resulting in acute col chicine toxicities.
Journal ArticleDOI

Left atrial strain, intervendor variability, and atrial fibrillation recurrence after catheter ablation: A systematic review and meta-analysis.

TL;DR: LAS prior to catheter ablation is consistently lower in patients that experience AF recurrence, and its incorporation in clinical practice would assist physicians detect patients that require closer follow-up.
Journal ArticleDOI

Iron deficiency as therapeutic target in heart failure: a translational approach.

TL;DR: Current knowledge on the role of iron in cardiac muscle cells, the contribution of ID to anemia and HF pathophysiology and the capacity of IV iron therapy to ameliorate the patients’ arrhythmogenic profile, quality of life, and prognosis are reviewed.